A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity
Advanced Science · 2026
DOI: 10.1002/advs.202510543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jimeen Yoo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Cardiotoxicity, Doxorubicin, RNA, Messenger, Myocytes, Cardiac. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Icahn School of Medicine at Mount Sinai and NIH.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Doxorubicin (Dox) is a widely employed chemotherapeutic agent, but its use is clinically limited by dose‐accumulative cardiotoxicity. More specifically, Dox induces oxidative stress and causes pro‐apoptotic ceramide accumulation in cardiomyocytes (CMs). Acid ceramidase (AC) modified mRNA (modRNA) has been shown to reduce ceramide levels and protect the heart following ischemic injury; however, therapeutic modRNA applications have been hindered by the need for invasive delivery. Here, we present a platform for minimally intrusive transmission of modRNA to the heart. This CM‐selective modRNA translational system (cmSMRTs) is encapsulated in lipid nanoparticles for intravenous (IV) delivery to enable systemic administration with high cardiac selectivity via microRNA‐guided translational control (miR143 and miR122) to suppress off‐target expression in other tissues, including tumors. In vitro, AC treatment preserved sarcomere structure, calcium handling, and mitochondrial function in Dox‐treated human induced pluripotent stem cell (iPSC)‐derived CMs. Moreover, weekly IV delivery of this modRNA prevented cardiac dysfunction, fibrosis, and atrophy in chronic Dox‐induced cardiotoxicity models. Notably, this cardioprotection is achieved without either compromising Dox's anti‐tumor efficacy or producing overall toxicity. These findings establish cmSMRTs 143‐122 as a minimally invasive, cardiac‐selective mRNA therapy platform with strong potential to prevent chemotherapy‐induced cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Cell, Development/Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Medicine, Division of Cardiology, Center for Cardiovascular Research, Washington University, Saint Louis, Missouri, USA.
ORCID-Profile: Lior Zangi
Förderung
- Icahn School of Medicine at Mount Sinai and NIH
Zitieren
APA
Yoo, J., Mainkar, G., Ghiringhelli, M., Santos, B. G. D., Żak, M. M., Kaur, K., Kurian, A. A., Adjmi, M., Sharon, S., Markopoulou, E., Žigová, L., Hirsch, D., Pessin, S., Hanan, R., Abreu, J. L. E., Brisnovali, N., Dubois, N., Goedeke, L., Shen, M., & Zangi, L. (2026). A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity. Advanced Science. https://doi.org/10.1002/advs.202510543
Vancouver
Yoo J, Mainkar G, Ghiringhelli M, Santos BGD, Żak MM, Kaur K, et al. A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity. Advanced Science. 2026. doi:10.1002/advs.202510543
BibTeX
@article{Yoo2026,
author = {Yoo, Jimeen and Mainkar, Gayatri and Ghiringhelli, Matteo and Santos, Bernardo Gindri Dos and Żak, Magdalena M and Kaur, Keerat and Kurian, Ann Anu and Adjmi, Matthew and Sharon, Segev and Markopoulou, Eftychia and Žigová, Lucia and Hirsch, Daniela and Pessin, Sydney and Hanan, Rachel and Abreu, Juan Luis Escano and Brisnovali, Niki and Dubois, Nicole and Goedeke, Leigh and Shen, Mengcheng and Zangi, Lior},
title = {A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202510543}
}
EUVIMED